<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04327258</url>
  </required_header>
  <id_info>
    <org_study_id>041/09e</org_study_id>
    <nct_id>NCT04327258</nct_id>
  </id_info>
  <brief_title>The Influence of NPPA/NPPB Haplotype on Natriuretic Peptide Plasma Levels</brief_title>
  <official_title>The Influence of NPPA/NPPB Haplotype on Natriuretic Peptide Plasma Levels</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Inselspital, Berne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Inselspital, Berne</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Crosssectional study to analyse the genetic influence on levels of cardiac biomarkers (BNP,
      NT-proBNP).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background

      Natriuretic peptides play an important role in risk stratification and management of patients
      undergoing non-cardiac surgery. However, due to genetic variability, the levels of these
      biomarkers may differ in individual patients with cardiac derangement. In the preoperative
      setting, genetic contribution to natriuretic peptide plasma level variability has not yet
      been determined.

      Objective

      The aim of this study is to assess genetic contribution to NP plasma level variability in a
      Swiss cohort.

      Methods

      Cross-sectional association study in a cohort of non-cardiac surgery patients.

      This study is a Subproject of a prospective cohort study registered under the ID 041/09.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2011</start_date>
  <completion_date type="Actual">December 2014</completion_date>
  <primary_completion_date type="Actual">December 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Influence of NPPA/NPPB haplotype on natriuretic peptide plasma levels</measure>
    <time_frame>Blood samples collected at start of anesthetic procedure</time_frame>
    <description>Estimation of genetic effects on natriuretic peptide (BNP, NT-proBNP) plasma levels</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">437</enrollment>
  <condition>Anesthesia</condition>
  <condition>Surgical Procedure, Operative</condition>
  <arm_group>
    <arm_group_label>All patients</arm_group_label>
    <description>Patients undergoing elective surgery with anesthesia</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Whole blood (plasma and cells)
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients scheduled for elective surgery
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 years and older

          -  Written informed consent

          -  Scheduled surgery

        Exclusion Criteria

          -  No informed consent

          -  Cognitive impairment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Frank St√ºber, Prof. MD</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Anaesthesiology and Pain Medicine, Inselspital, University of Bern</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ulrike M Stamer, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Anaesthesiology and Pain Medicine, Inselspital, University of Bern</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Anaesthesiology and Pain Medicine, Inselspital, University of Bern</name>
      <address>
        <city>Bern</city>
        <zip>3010</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>March 26, 2020</study_first_submitted>
  <study_first_submitted_qc>March 26, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 31, 2020</study_first_posted>
  <last_update_submitted>March 26, 2020</last_update_submitted>
  <last_update_submitted_qc>March 26, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 31, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>genetic association study</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

